The vaccine, mycobacterium indicus pranii (MIP), which has been developed in India, is associated with prevention of which disease?
Mycobacterium Indicus Pranii (MIP) is the world’s first vaccine developed in India for prevention of leprosy, and India will be the first to have a large-scale vaccination programme. The vaccine has been developed by G P Talwar of National Institute of Immunology and has been approved by the Drug Controller General of India (DCGI) and the US-FDA. About 60% of the global leprosy patients live in India. The vaccine will help in eradicating the menace of Leprosy in India. The vaccine is now being used as a part of pilot programme in few districts of India, and if shows satisfactory results, the programme will be implemented in other high-prevalence districts across the country.
This question is a part of GKToday's Integrated IAS General Studies Module